Atorvastatin as an adjuvant with betamethasone valerate reduces disease severity and cardiovascular risks in Psoriasis

OBJECTIVES: To evaluate the effect of Atorvastatin as an adjuvant with betamethasone valerate on disease severity and cardiovascular risks in chronic plaque type psoriatic patients. METHODS: It is an interventional study conducted in Pharmacology Department of BMSI, JPMC with the collaboration of De...

Descripción completa

Detalles Bibliográficos
Autores principales: Asad, Farah, Khan, Moosa, Rizvi, Fatima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768853/
https://www.ncbi.nlm.nih.gov/pubmed/29492087
http://dx.doi.org/10.12669/pjms.336.14068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768853/
https://www.ncbi.nlm.nih.gov/pubmed/29492087
http://dx.doi.org/10.12669/pjms.336.14068

Ejemplares similares